AX-024 hydrochloride
AX-024 hydrochloride Basic information
- Product Name:
- AX-024 hydrochloride
- Synonyms:
-
- AX-024;AX024;AX 024
- AX-024 hydrochloride
- AX-024
- 1-((4-(4-Fluorophenyl)-6-methoxy-2H-chromen-3-yl)methyl)pyrrolidine hydrochloride
- AX 024,Interleukin Related,Inhibitor,inhibit,Tumor Necrosis Factor Receptor,AX024 hydrochloride,TNFR,Interferon-α/β receptor,AX024,AX-024,IFNAR,TNF Receptor,AX 024 hydrochloride,Interferon-alpha/beta receptor
- CAS:
- 1704801-24-0
- MF:
- C21H23ClFNO2
- MW:
- 375.87
- Mol File:
- 1704801-24-0.mol
AX-024 hydrochloride Chemical Properties
- storage temp.
- -20°
- solubility
- Soluble in DMSO (up to at least 25 mg/ml with warming) or in Water (10 mg/ml with warming).
- form
- solid
- color
- White
- Stability:
- Stable for 1 year from date of purchase as supplied. Solutions in DMSO or distilled water may be stored at -20° for up to 3 months.
AX-024 hydrochloride Usage And Synthesis
Description
AX-024 is an inhibitor of the CD3ε-Nck interaction. It binds to the SH3.1 N-terminal domain of Nck1, preventing its binding to the proline-rich sequence of the CD3ε subunit of T cells. AX-024 inhibits T cell receptor-triggered T cell activation (IC50 = 1 nM for human T cells) and selectively decreases proliferation of T cells over B cells. It prevents CD4+ T cell and macrophage infiltration to the cerebellum and spinal cord and improves neurological impairments in a MOG35-55 mouse model of experimental autoimmune encephalomyelitis (EAE) when administered at a dose of 10 mg/kg per day for ten days starting on the day of immunization. AX-024 (50 mg/kg) prevents the infiltration of eosinophils, macrophages, and neutrophils into the airway, as well as prevents an increase in IL-4 levels in bronchoalveolar lavage fluid (BALF), in an ovalbumin-sensitized mouse model of allergic airway disease. It does not prevent the memory T cell response to an immunodominant B8R poxvirus antigen peptide or to infection by ectromelia virus (mousepox).
Uses
AX-024 is a T cell receptor inhibitor for the treatment of autoimmune diseases.
References
1) Borroto et al. (2016), First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases; Sci. Transl. Med., 8 370ra184
AX-024 hydrochlorideSupplier
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
- Tel
- 021-52996696,15000506266 15000506266
- Tel
- 021-65675885 18964387627
- info@efebio.com
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
- Tel
- 21-31433387 15618786686
- sales@rechemscience.com